EISSN 2980-1478

INDEXED IN WEB OF SCIENCE AND SCOPUS INDEXED IN PUBMED CENTRAL

Urology Research & Practice

50 218 2024

HIGHLY CITED ARTICLES

Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study

By: Shah et al.

What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic

By: Ho et al.

Thulium fiber laser: The new kid on the block

By: Schembri et al.

Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer

By: Danarto et al.

The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades

By: Gamage et al.

Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy

By: Murray et al.

Problems and solutions of stent biofilm and encrustations: A review of literatüre

By: Khoddami et al.

First case of retroperitoneal hematoma in COVID-19

By: Scialpi et al.

Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases

By: Yalçın et al.

Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis

By: By: Ortner et al.

Invited Review

A Urologist’s Personal View of Prostate Cancer

Paul F. Schellhammer ¹

Author Affiliation(s)

1.

Department of Urology, Eastern Virginia Medical School Urology of Virginia, USA

Urol Res Pract 2016; 42: 121-126

DOI: 10.5152/tud.2016.50318

Keywords : Cancer; prostate; treatment

Read: 1516 Downloads: 974 Published: 25 July 2019

Volume 42, Issue 3, September 2016

Previous Article

Abstract

A urologist’s personal experience with multiple surgical, hormonal, and radio/immunotherapeutic options for the treatment of advanced prostate cancer and thoughts on the role of old and new therapies.

Files